CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
暂无分享,去创建一个
W. Pickl | E. Holler | H. Greinix | W. Rabitsch | P. Kalhs | M. Edinger | Z. Kuzmina | M. Mitterbauer | D. Wolff | Ulrike Körmoczi | Arno Rottal | Roman Weigl | Mateja Kralj
[1] B. Blazar,et al. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets. , 2017, The New England journal of medicine.
[2] H. Greinix,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .
[3] J. Ritz,et al. Current issues in chronic graft-versus-host disease. , 2014, Blood.
[4] S. Roedder,et al. Biologic markers of chronic GVHD , 2014, Bone Marrow Transplantation.
[5] T. Braun,et al. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis. , 2014, Blood.
[6] G. Dekan,et al. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome. , 2013, Blood.
[7] G. Alter,et al. Decoupling activation and exhaustion of B cells in spontaneous controllers of HIV infection , 2013, AIDS.
[8] A. Böhm,et al. Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study , 2012, Leukemia.
[9] J. Ritz,et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. , 2011, The New England journal of medicine.
[10] R. Storb,et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. , 2011, Blood.
[11] W. Pickl,et al. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. , 2011, Blood.
[12] J. Ritz,et al. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. , 2011, Blood.
[13] G. Socié. Chronic GVHD: B cells come of age. , 2011, Blood.
[14] D. Hafler,et al. FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.
[15] J. Ritz,et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. , 2010, The Journal of clinical investigation.
[16] S. Tangye,et al. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. , 2010, Blood.
[17] Hermann Einsele,et al. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.
[18] M. Kouba,et al. Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. , 2009, Blood.
[19] J. Ritz,et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. , 2009, Blood.
[20] A. Thiel,et al. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. , 2009, Blood.
[21] J. Sprent,et al. Homeostasis of naive and memory T cells. , 2008, Immunity.
[22] G. Cuvelier,et al. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. , 2008, Blood.
[23] M. Kouba,et al. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[24] J. Phair,et al. Homeostasis of the Naive CD4+ T Cell Compartment during Aging1 , 2008, The Journal of Immunology.
[25] R. Zufferey,et al. Correlation between recent thymic emigrants and CD31+ (PECAM‐1) CD4+ T cells in normal individuals during aging and in lymphopenic children , 2007, European journal of immunology.
[26] J. Ritz,et al. High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease , 2007, Clinical Cancer Research.
[27] R. Gress,et al. T cell immune reconstitution following lymphodepletion. , 2007, Seminars in immunology.
[28] M. Tanimoto,et al. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. , 2007, Blood.
[29] James Ferrara,et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[30] Daniel Wolff,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[31] A. Cumano,et al. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation. , 2005, Experimental hematology.
[32] M. Pierer,et al. Post‐thymic in vivo proliferation of naive CD4+ T cells constrains the TCR repertoire in healthy human adults , 2005, European journal of immunology.
[33] T. Phan,et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.
[34] C. Craddock,et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. , 2004, Blood.
[35] Catherine J. Wu,et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. , 2004, Blood.
[36] M. Flowers,et al. Chronic graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[37] John P Klein,et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. , 2002, Blood.
[38] Andreas Radbruch,et al. Two Subsets of Naive T Helper Cells with Distinct T Cell Receptor Excision Circle Content in Human Adult Peripheral Blood , 2002, The Journal of experimental medicine.
[39] H. Illges,et al. Regulation of CD21 expression by DNA methylation and histone deacetylation. , 2001, International immunology.
[40] R. Collins,et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. , 2001, Blood.
[41] C. Thoburn,et al. Autoreactive T-Cell subsets in acute and chronic syngeneic graft-versus-host disease. , 2001, Transplantation proceedings.
[42] J. V. Stone,et al. Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation , 1999 .
[43] J. Tschopp,et al. BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth , 1999, The Journal of experimental medicine.
[44] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[45] M. Dehoff,et al. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. , 1998, Journal of immunology.
[46] V. M. Holers,et al. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. , 1997, Journal of immunology.
[47] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.
[48] D. Fearon,et al. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. , 1988, Journal of immunology.
[49] P. Schur,et al. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. , 1986, Arthritis and rheumatism.
[50] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.
[51] C. Dziuban,et al. When is a correlation matrix appropriate for factor analysis? Some decision rules. , 1974 .
[52] H. Kaiser. A second generation little jiffy , 1970 .
[53] J. G. Cragg,et al. The Demand for Automobiles , 1970 .
[54] J. Ritz,et al. Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. , 2012, Blood.
[55] K. Safranow,et al. CD 4 + CD 25 high regulatory T cells and CD 4 + CD 69 + T cells in peripheral blood of patients with cutaneous lupus erythematosus , 2009 .
[56] K. Schultz. Chronic Graft versus Host Disease: Interdisciplinary Management: Pathophysiology of Chronic Graft versus Host Disease , 2009 .
[57] M. Turner,et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[58] J. V. Stone,et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. , 1999, The New England journal of medicine.
[59] O. Majdic,et al. Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. , 1992, Immunology.